NCT05026736 2025-08-17
Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study
M.D. Anderson Cancer Center
Phase 2 Terminated
Clinical Trials
4 trialsNCT05161572 2025-06-18
NeoRacing
Fudan University
Phase 2 Terminated
NCT05017103 2024-12-11
Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT04653389 2022-01-11
Perioperative Therapy for Hepatocellular Carcinoma
Zhejiang University
Phase 2 Terminated